Topographic Gene Expression in the Sinonasal Cavity of Patients with Chronic Sinusitis with Polyps

Abstract

Objective To determine whether variations in gene expression exist at multiple subsites along the sinonasal tract in patients with chronic sinusitis with polyps and in healthy controls. Study Design Prospective, controlled study. Setting Academic medical center. Subjects and Methods Tissue expression levels of 5 genes, previously found to be characteristic of ethmoid polyps, were measured using real-time quantitative polymerase chain reaction in 100 sinonasal tissue samples. Specimens harvested from 5 regions—the ethmoid sinus, septum, inferior turbinate, middle turbinate, and lateral nasal wall—in 10 patients with chronic sinusitis and ethmoid polyps were compared to tissue from similar regions in 10 control patients without sinusitis. Western blot analysis was performed to validate differential gene expression at the protein level. Results Gene expression levels of ethmoid polyps differed significantly from those of healthy ethmoid mucosa, as well as tissue from 4 surrounding anatomical sites in both patients with chronic sinusitis and controls. Alterations specific to the polyp tissue included downregulated genes, prolactin-induced protein (fold change 377.2 ± 169.0, P < .0001), and zinc α2-glycoprotein (fold change 72.1 ± 26.5, P < .0001), as well as upregulated genes, met proto-oncogene (fold change 2.5 ± 0.7, P = .029), and periostin (fold change 7.5 ± 3.4, P = .003). No significant differences in gene expression was found for neurabin 2 (fold change 1.0, P = .99). Conclusion The transcriptional pattern of ethmoid polyps appears to be unique compared with other subsites in the sinonasal cavity of patients with chronic sinusitis. Care must be taken when collecting specimens for molecular studies of the sinonasal tract to differentiate polyp from nonpolyp tissue in chronic sinusitis.

Factors affecting time to revision sinus surgery for nasal polyps: A 25‐year experience

“…Although a history of asthma has been associated with both the presence of nasal polyps and their recurrence, in the current study asthma was not found to impact the time to revision sinus surgery in patients with CRSwNP. Severity of CT stage was also not found to be a significant factor in predicting time to revision surgery.…”

Periostin and receptor activator of nuclear factor κ‐B ligand expression in allergic fungal rhinosinusitis

“…This was confirmed through the implementation of 2 distinct identification techniques, sq-RT-PCR and immunofluorescence. Although sq-RT-PCR has been widely used in past studies, 9,10 this is also the first time, to our knowledge, that immunofluorescence labeling and confocal microscopy has been used to detect periostin protein in sinonasal tissue. This allowed for another method by which to validate periostin's presence in sinonasal tissue and as well as relatively quantify it across tissue samples.…”

“…9 These increased periostin levels were found to be specific to the polypoid tissue sample itself and not universally elevated in samples of adjacent "healthy" mucosa from the same patient. 10 However, despite periostin's significant role in Th-2-mediated pathways, eosinophil recruitment, mucus production, and sinonasal inflammatory disease, it has yet to be evaluated in patients with AFRS.…”

Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines

“…Recent attempts to identify inflammatory endotypes have presented a more nuanced approach to the classification of CRS, with Tomassen et al recently using surgically-obtained tissue to identify potential CRS endotypes based entirely on inflammatory biomarkers 4 . While such studies have preferentially used tissue-based assessment of inflammatory mediators, this approach may have some logistical limitations as it is inherently invasive and subject to variations in site-specific protein expression throughout the sinonasal cavity 5, 6 . Minimally invasive approaches to disease endotyping have been reported for asthma and other respiratory diseases, typically employing analysis of sputum, mucus, or epithelial brushings 7–9 .…”